Key result
Nonischemic late gadolinium enhancement during stress-CMR was associated with a higher rate of composite cardiovascular events compared to no LGE.
Why the study?
The prevalence and prognostic significance of nonischemic late gadolinium enhancement in patients undergoing stress-CMR needed to be assessed.
Does the presence of nonischemic late gadolinium enhancement on stress-CMR predict adverse cardiovascular outcomes in patients undergoing stress-CMR?
Cohort (n=283)
Does the presence of nonischemic late gadolinium enhancement on stress-CMR predict adverse cardiovascular outcomes in patients undergoing stress-CMR?
The presence of nonischemic late gadolinium enhancement on stress-CMR is detected in 11% of patients and is associated with a worse prognosis compared to those without LGE.
Answers are grounded in this paper and cite their sources.
NI-LGE on stress-CMR flags higher event risk; leaves open whether routine reporting improves risk stratification beyond perfusion.
AIM: To assess the prevalence and prognostic significance of NI-LGE in patients undergoing stress-CMR. METHODS: Stress-CMR with either dipyridamole or adenosine was performed in 283 patients (228 men, 81%) including perfusion imaging, wall motion evaluation and LGE. Follow-up was completed in all enrolled patients (median time: 1850 days; interquartile range: 1225-2705 days). Composite endpoint included cardiac death, ventricular tachycardia, myocardial infarction, stroke, hospitalization for cardiac cause and coronary revascularization performed beyond 90 days from stress-CMR scans. RESULTS: One hundred and twelve patients (40%) had negative LGE (no-LGE), 140 patients (49%) I-LGE and 31 patients (11%) NI-LGE. Twenty-five events occurred in the no-LGE group, 68 in I-LGE and 11 in the NI-LGE group. On survival curves, patients with NI-LGE had worse prognosis than patients with no-LGE regardless of the presence of inducible perfusion defects. No significant prognostic differences were found between I-LGE and NI-LGE. CONCLUSION: NI-LGE can be detected in 11% of patients during stress-CMR providing a diagnosis of nonischemic cardiac disease. Patients with NI-LGE have worse prognosis than those with no-LGE.
No takes yet. Share an insight, caveat, or question.
Grigoratos et al. (2020) conducted a cohort in Patients undergoing stress-CMR (n=283). Nonischemic late gadolinium enhancement (NI-LGE) vs. No LGE was evaluated on Composite of cardiac death, ventricular tachycardia, myocardial infarction, stroke, hospitalization for cardiac cause and coronary revascularization beyond 90 days. Nonischemic late gadolinium enhancement during stress-CMR was associated with a higher rate of composite cardiovascular events compared to no LGE.
Synapse has enriched 10 related papers. Consider them for comparative context: